379239
三甲基铝 溶液
2.0 M in heptane
别名:
Aluminum trimethanide solution
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
(CH3)3Al
化学文摘社编号:
分子量:
72.09
UNSPSC Code:
12352103
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
3587197
InChI
1S/3CH3.Al/h3*1H3;
SMILES string
C[Al](C)C
InChI key
JLTRXTDYQLMHGR-UHFFFAOYSA-N
form
liquid
concentration
2.0 M in heptane
density
0.693 g/mL at 25 °C
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
Trimethylaluminum can be used in the synthesis of methylaluminoxane (MAO), a precatalyst for olefin polymerization. It is a precursor for the preparation of a wide range of organoaluminium such as dimethylaluminum chloride and bis(trimethylaluminum)-1,4-diazabicyclo[2.2.2]-octane (DABAL-Me3).
signalword
Danger
Hazard Classifications
Aquatic Acute 1 - Aquatic Chronic 1 - Asp. Tox. 1 - Eye Dam. 1 - Flam. Liq. 2 - Pyr. Liq. 1 - Skin Corr. 1B - STOT SE 3 - Water-react 1
target_organs
Central nervous system
supp_hazards
存储类别
4.2 - Pyrophoric and self-heating hazardous materials
wgk
WGK 2
flash_point_f
-0.4 °F - closed cup
flash_point_c
-18 °C - closed cup
ppe
Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter
法规信息
新产品
此项目有
Remarkably Stable (Me3Al) 2? DABCO and Stereoselective Nickel?Catalyzed AlR3 (R= Me, Et) Additions to Aldehydes.
Biswas K, et al.
Angewandte Chemie (International Edition in English), 44(15), 2232-2234 (2005)
Gasometric titration for dimethylaluminum chloride analysis.
Wang L, et al.
Journal of Pharmaceutical and Biomedical Analysis, 125, 110-113 (2016)
Methylaluminoxane: synthesis, characterization and catalysis of ethylene polymerization.
Reddy S S, et al.
Polymer Bull., 36(2), 165-171 (1996)
Mahtab Farzin et al.
Pathology, 47(4), 302-307 (2015-05-06)
BRCA1-associated protein 1 (BAP1) is a tumour suppressor gene frequently inactivated in mesothelioma, rarely also in association with germline mutation. BAP1 mutations have been associated with improved prognosis and distinct clinicopathological features. We sought to determine the clinicopathological significance of
J L L Robinson et al.
Oncogene, 33(50), 5666-5674 (2013-12-03)
Castration-resistant prostate cancer (CRPC) continues to pose a significant clinical challenge with new generation second-line hormonal therapies affording limited improvement in disease outcome. As the androgen receptor (AR) remains a critical driver in CRPC, understanding the determinants of its transcriptional
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持